Finding the RNA aptamer in the haystack that could improve treatment for Parkinson's

Synucleinopathies are a radical of neurodegenerative disorders that see superior conditions specified arsenic Parkinson's illness and dementia with Lewy bodies. There are presently nary cures for these disorders, and attraction is constricted to mitigating symptoms. Recently, antibody-based therapies person attracted sizeable attention, but alternate approaches are inactive necessary.